201 related articles for article (PubMed ID: 24161107)
1. Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2.
Ye Y; Cheng X; Zhang J; Tong T; Lin W; Liao M; Fan H
Virol J; 2013 Oct; 10():316. PubMed ID: 24161107
[TBL] [Abstract][Full Text] [Related]
2. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.
Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S
J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
4. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.
Xu XG; Wang ZS; Zhang Q; Li ZC; Ding L; Li W; Wu HY; Chang CD; Lee LH; Tong DW; Liu HJ
J Virol Methods; 2012 Feb; 179(2):359-66. PubMed ID: 22172969
[TBL] [Abstract][Full Text] [Related]
5. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
Jung BK; Kim HR; Jang H; Chang KS
J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
[TBL] [Abstract][Full Text] [Related]
8. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.
Wang X; Jiang W; Jiang P; Li Y; Feng Z; Xu J
Vaccine; 2006 Apr; 24(16):3374-80. PubMed ID: 16524646
[TBL] [Abstract][Full Text] [Related]
9. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
[TBL] [Abstract][Full Text] [Related]
10. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18.
Zheng LL; Guo XQ; Zhu QL; Chao AJ; Fu PF; Wei ZY; Wang SJ; Chen HY; Cui BA
Virus Res; 2015 Apr; 201():8-15. PubMed ID: 25701744
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
[TBL] [Abstract][Full Text] [Related]
14. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
15. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
16. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
[TBL] [Abstract][Full Text] [Related]
18. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
20. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
